WR Wealth Planners LLC Lowers Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

WR Wealth Planners LLC trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 54.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 338 shares of the medical equipment provider’s stock after selling 399 shares during the quarter. WR Wealth Planners LLC’s holdings in Intuitive Surgical were worth $176,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in ISRG. Berbice Capital Management LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $26,000. BankPlus Trust Department acquired a new stake in shares of Intuitive Surgical in the fourth quarter worth $28,000. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical in the third quarter worth $33,000. Decker Retirement Planning Inc. acquired a new stake in shares of Intuitive Surgical in the fourth quarter worth $36,000. Finally, Capital Performance Advisors LLP acquired a new stake in Intuitive Surgical during the 3rd quarter valued at $38,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $573.15 on Friday. The stock’s fifty day moving average is $569.87 and its 200 day moving average is $529.06. The stock has a market capitalization of $204.14 billion, a P/E ratio of 89.42, a PEG ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00.

Analysts Set New Price Targets

A number of research analysts have commented on ISRG shares. Raymond James increased their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Jefferies Financial Group increased their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. Piper Sandler reaffirmed an “overweight” rating and issued a $670.00 price objective (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Finally, Citigroup raised their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $613.10.

Insider Activity

In other Intuitive Surgical news, EVP Myriam Curet sold 2,401 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $581.00, for a total value of $1,394,981.00. Following the completion of the sale, the executive vice president now directly owns 353 shares in the company, valued at approximately $205,093. The trade was a 87.18 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 8,077 shares of company stock valued at $4,620,025. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.